|
Q4 2021
Filed on Feb 11, 2022
|
25,319
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
2,918
|
$75.2 - $88.55
$219K - $258K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
18,002
|
$1.88 - $2.9
$33.8K - $52.2K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
773
|
$630.6 - $703.62
$487K - $544K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
57,573
|
$1.24 - $2.31
$71.4K - $133K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
20,736
|
$3.76 - $7.99
$78K - $166K
|
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
13,289
|
$2.27 - $3.0
$30.2K - $39.9K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
14,723
|
$10.86 - $12.69
$160K - $187K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
9,110
|
$28.4 - $48.53
$259K - $442K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
30,847
|
$1.0 - $2.0
$30.8K - $61.7K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
6,862
|
$35.23 - $41.89
$242K - $287K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
1,862
|
N/A
|
|
Eyegate Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 11, 2022
|
13,867
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
1,334
|
$167.89 - $226.73
$224K - $302K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,383
|
$1.56 - $2.99
$16.2K - $31K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
15,882
|
$0.58 - $1.09
$9.21K - $17.3K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
23,516
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,453
|
$2.04 - $3.65
$21.3K - $38.2K
|
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,528
|
$2.46 - $3.94
$30.8K - $49.4K
|
|
Dicerna Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 11, 2022
|
17,008
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
5,143
|
$45.08 - $55.96
$232K - $288K
|
|
Investors Bancorp Inc New
|
Q4 2021
Filed on Feb 11, 2022
|
18,680
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
2,223
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
13,883
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
3,141
|
$135.09 - $159.72
$424K - $502K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
19,990
|
$0.01 - $0.19
$200 - $3.8K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
3,156
|
$106.52 - $122.34
$336K - $386K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
18,114
|
$8.3 - $12.0
$150K - $217K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,144
|
$1.76 - $2.44
$17.9K - $24.8K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
4,067
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
20,982
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,578
|
$29.43 - $37.6
$194K - $247K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
17,730
|
$4.1 - $5.42
$72.7K - $96.1K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
18,550
|
$1.49 - $2.77
$27.6K - $51.4K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,362
|
N/A
|
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,815
|
$26.0 - $27.01
$385K - $400K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,875
|
$1.72 - $5.9
$22.1K - $76K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
3,360
|
N/A
|
|
Aerpio Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
17,331
|
N/A
|
|
Adamas Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
16,357
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,444
|
$20.03 - $22.59
$249K - $281K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
76,941
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,846
|
$2.77 - $3.74
$30K - $40.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,901
|
$0.88 - $1.22
$13.1K - $18.2K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,822
|
$4.57 - $5.39
$58.6K - $69.1K
|
|
Dragoneer Growth Opportun CO
|
Q3 2021
Filed on Nov 12, 2021
|
10,140
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
16,081
|
$12.73 - $14.02
$205K - $225K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
18,640
|
$2.21 - $2.89
$41.2K - $53.9K
|
|
Ashford Hospitality Tr Inc
|
Q3 2021
Filed on Nov 12, 2021
|
12,136
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
15,876
|
N/A
|
|